BOOST BIOPHARMA Trademark
Trademark Overview
On Wednesday, January 5, 2022, a trademark application was filed for BOOST BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the BOOST BIOPHARMA trademark a serial number of 97203987. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Monday, June 15, 2026. This trademark is owned by Boost Biopharma, Inc.. The BOOST BIOPHARMA trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
biological and chemical preparations, and substances, comprising nucleic acids and sequences thereof, amino acids and sequences thereof, peptides, proteins, or combinations of the forgoing, for the development of vaccines for scientific and medical purposes; Nucleic acids and proteins in raw material form for scientific and medical purposes
vaccines, nucleic acid sequences and chemical reagents for medical and veterinary purposes, and protein arrays for medical diagnostic purposes; pharmaceutical and biological preparations and substances, comprising nucleic acids, amino acids, peptides, proteins, or combinations of these, for the diagnosis, prevention, and treatment of bacterial, viral, and parasitic infectious disease, and cancer, for use in connection with humans and animals; pharmaceutical and biological products, namely, diagnostic products, prophylactic products, therapeutic products, vaccines and antibodies for bacterial, viral, and parasitic infectious disease, and vaccines and antibodies for cancer, for use in connection with humans and animals for medical or veterinary purposes; diagnostic preparations for use in connection with humans and animals for medical or veterinary purposes; diagnostic products being diagnostic preparations for use in connection with humans and animals for medical or veterinary purposes
Medical and pharmaceutical research and development of vaccines, nucleic acids, and proteins for use in connection with humans and animals; Medical and pharmaceutical research and development of medical diagnostics for use in connection with humans and animals; Medical and pharmaceutical research and development of vaccine platform technologies; Medical and pharmaceutical research and development of proteins and nucleic acids; Medical and pharmaceutical research and development of medical diagnostics; biomedical research services; pharmaceutical and biological product development services; pharmaceutical and biological product development consulting
General Information
| Serial Number | 97203987 |
| Word Mark | BOOST BIOPHARMA |
| Filing Date | Wednesday, January 5, 2022 |
| Status | 654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED |
| Status Date | Monday, June 15, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| NOT AVAILABLE | "BIOPHARMA" |
| Goods and Services | biological and chemical preparations, and substances, comprising nucleic acids and sequences thereof, amino acids and sequences thereof, peptides, proteins, or combinations of the forgoing, for the development of vaccines for scientific and medical purposes; Nucleic acids and proteins in raw material form for scientific and medical purposes |
| Goods and Services | vaccines, nucleic acid sequences and chemical reagents for medical and veterinary purposes, and protein arrays for medical diagnostic purposes; pharmaceutical and biological preparations and substances, comprising nucleic acids, amino acids, peptides, proteins, or combinations of these, for the diagnosis, prevention, and treatment of bacterial, viral, and parasitic infectious disease, and cancer, for use in connection with humans and animals; pharmaceutical and biological products, namely, diagnostic products, prophylactic products, therapeutic products, vaccines and antibodies for bacterial, viral, and parasitic infectious disease, and vaccines and antibodies for cancer, for use in connection with humans and animals for medical or veterinary purposes; diagnostic preparations for use in connection with humans and animals for medical or veterinary purposes; diagnostic products being diagnostic preparations for use in connection with humans and animals for medical or veterinary purposes |
| Goods and Services | Medical and pharmaceutical research and development of vaccines, nucleic acids, and proteins for use in connection with humans and animals; Medical and pharmaceutical research and development of medical diagnostics for use in connection with humans and animals; Medical and pharmaceutical research and development of vaccine platform technologies; Medical and pharmaceutical research and development of proteins and nucleic acids; Medical and pharmaceutical research and development of medical diagnostics; biomedical research services; pharmaceutical and biological product development services; pharmaceutical and biological product development consulting |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, April 15, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 10, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 10, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Boost Biopharma, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Wilmington, DE 19808
US |
Trademark Events
| Event Date | Event Description |
| Saturday, January 8, 2022 | NEW APPLICATION ENTERED |
| Monday, January 10, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 11, 2022 | ASSIGNED TO EXAMINER |
| Friday, October 14, 2022 | NON-FINAL ACTION WRITTEN |
| Friday, October 14, 2022 | NON-FINAL ACTION E-MAILED |
| Friday, October 14, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, April 14, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, April 14, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, April 15, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 17, 2023 | SUSPENSION LETTER WRITTEN |
| Monday, April 17, 2023 | LETTER OF SUSPENSION E-MAILED |
| Monday, April 17, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, December 6, 2023 | ASSIGNED TO EXAMINER |
| Friday, December 22, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Thursday, November 28, 2024 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Wednesday, May 28, 2025 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Monday, December 15, 2025 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Monday, June 15, 2026 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
